EquityFolio

RVMDW

NASDAQ

Revolution Medicines, Inc. Warrant

$11.29

$0.23 (+2.08%)

Live quote

52w: $10.60 – $11.30

Loading chart…
P/E Ratio
P/B Ratio0.91
EV/EBITDA
Debt/Equity
ROE-43.41%
ROIC
Revenue Growth
Gross Margin
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops therapies to inhibit frontier targets in RAS-addicted cancers. The company is headquartered in Redwood City, California.

Own RVMDW? Track it here.

Create a free account to add RVMDW to a portfolio and watch your P/L update in real time.

Custom screens, valuation models and backtesting are coming to Pro.

Create a free account